American Express to Participate in UBS Financial Services Conference

NEW YORK--(BUSINESS WIRE)-- American Express Company (NYSE: AXP) will participate in the UBS Financial Services Conference on Monday, February 10, 2025, at 10:30 a.m. Eastern.

A live audio webcast of a discussion about the company’s business strategy and financial performance will be accessible to the general public through the American Express Investor Relations website at http://ir.americanexpress.com. An audio replay of the discussion will be available after the event at the same website address.

ABOUT AMERICAN EXPRESS

American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress, instagram.com/americanexpress, linkedin.com/company/american-express, X.com/americanexpress, and youtube.com/americanexpress.

Key links to products, services and corporate sustainability information: personal cards, business cards and services, travel services, gift cards, prepaid cards, merchant services, Business Blueprint, Resy, corporate card, business travel, corporate sustainability and Environmental, Social, and Governance reports.

The above-referenced discussion may include forward-looking statements that are subject to risks and uncertainties and speak only as of the date on which they are made. Important factors that could cause actual results to differ materially are set forth in the company’s filings with the U.S. Securities and Exchange Commission.

Source: American Express Company

Location: Global

View source version on businesswire.com: https://www.businesswire.com/news/home/20250114877648/en/

Media:
Melanie Backs, [email protected], +1.212.640.2164
Becca Moomjian, [email protected], +1.212.640.2164

Investors/Analysts:
Kartik Ramachandran, [email protected], +1.212.640.5574
Kristy Ashmawy, [email protected], +1.212.640.5574

Source: American Express Company

You May Also Be Interested In

• Activist Jana Partners takes 6.3% stake in Alkami Technology, urges sale
• FDA approves Arcutis' roflumilast cream for plaque psoriasis in children 2+
• Supreme Court declines SEC gag rule case review